Behavioral and Cognitive Therapies for Auditory Hallucination Management (AcceptVoice)

Toulouse University Hospital

Status: Completed

Conditions: Chronic Psychosis

Treatments: Behavioral: Behavioral and Cognitive Therapies

Study type: Interventional

Funder types: Other

Identifiers

NCT03348787

RC31/17/0159

2017-A01929-44 (Registry Identifier)

Details and patient eligibility

About

The present study wants to evaluate the efficacy of a short psychoeducational type group intervention and Cognitive behavioral therapy (CBT) 3rd wave on the severity of hallucinatory Acoustico-Verbal (HAV) symptomatology in patients with schizophrenia.

Enrollment: 55 patients

Sex: All

Ages: 18 to 65 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Schizophrenic disorders, schizo-affective disorders
• Suffering from persistent HAV
• No change in symptomatology for 3 months.
• No anticipated change in antipsychotic treatment (anti-hallucinatory): olanzapine, risperidone, amisulpride, quetiapine, aripiprazole, loxapine, haloperidol, clopixol, modecate, nozinan, cyamemazine, piportil, clozapine
• Major patient, or major incompetent.

Exclusion criteria

• Mental retardation
• Subject participating in another search including an exclusion period still in progress at pre-inclusion

Trial design

Primary purpose: Treatment

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

55 participants in 1 patient group

Behavioral and Cognitive Therapies

Experimental group

Description:

Chronic psychotic patients will have Behavioral and Cognitive Therapies

Treatment:

Behavioral: Behavioral and Cognitive Therapies